The company also announced its intentions to seek FDA approval for EndeavorOTC, its over-the-counter product for adults with ADHD.
Akili announces 27% growth of EndeavorRx prescriptions in Q2
The company also announced its intentions to seek FDA approval for EndeavorOTC, its over-the-counter product for adults with ADHD.
